Rocket Lab's Strategic Pivot: Robotics Acquisition and SpaceX IPO Tailwind Propel Record Valuation

Rocket Lab is no longer just the scrappy challenger to SpaceX — it's becoming a vertically integrated space supplier, and the market is repricing accordingly. The company's decision to acquire robotic-arm specialist Motiv Space Systems for up to $60 million, announced alongside a record quarterly revenue of $200.35 million, has reinforced the narrative that Rocket Lab is building long-term industrial capacity, not just riding a hype wave.

Motiv, which supplied components for the Mars rover Perseverance, will now operate as Rocket Lab Robotics. The purchase, mostly in cash, brings critical in-house capability for producing complex robotic arms used on satellites — a move that deepens Rocket Lab's control over its supply chain and opens a new revenue stream. The acquisition dovetails with the company's broader plan to scale its space systems division, which already includes the communications firm Mynaric.

Record Backlog and the Neutron Milestone

The first-quarter numbers offer concrete evidence that demand is accelerating. Revenue jumped 63.4% year-over-year to $200.35 million, slightly ahead of expectations. The net loss narrowed to roughly $45 million, or $0.07 per share, in line with analyst forecasts. More telling is the order book: the backlog hit $2.2 billion, a record that grew 20.2% from the prior quarter. A large chunk came from a hypersonic launch contract with the U.S. Department of Defense.

Operationally, Rocket Lab achieved a symbolic milestone by producing its 1,000th Rutherford engine. All eyes are now on the Neutron rocket, whose maiden flight is slated for the end of 2026. Management sees it as the key to capturing the lucrative large-satellite-constellation market, with a long-term revenue target of $1.5 billion by 2029, when the company expects to be consistently profitable.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Stock Surge and Analyst Divergence

The market's response has been ferocious. Shares closed at $130.80 on the day, up 2.74%, just shy of the recent high of $132.55. The stock has gained 46.21% over the past month and 72.13% year-to-date. Over twelve months, the advance stands at a staggering 403.08%.

Analyst reactions have been broadly positive but not unanimous. New Street Research initiated coverage with a Buy and a $150 price target, the highest on the Street. Deutsche Bank and Needham lifted their targets to $120 and $121, respectively. Yet Goldman Sachs remains cautious, maintaining a Neutral rating and a $76 fair-value estimate, warning that the impending SpaceX initial public offering could trigger a "buy the rumor, sell the news" unwind. The consensus from 20 analysts still registers as a "Moderate Buy."

The SpaceX Catalyst and Insider Caution

SpaceX is expected to file its S-1 registration statement this Wednesday, with the IPO targeted for June. The transaction is projected to raise $75 billion at a valuation between $1.75 trillion and $2 trillion. That benchmark is already lifting the entire space sector, and Rocket Lab — as one of the few publicly traded pure plays — is benefiting disproportionately.

However, not all signals are unequivocally bullish. CEO Peter Beck and CFO Adam Spice sold blocks of shares earlier this spring at prices around $69.59, a move that, while not necessarily ominous, draws closer scrutiny after such a steep rally. The stock's price-to-sales ratio of roughly 81 leaves little room for error. Technicians point to a support zone near $100, suggesting the recent gains could be tested if the SpaceX event triggers profit-taking.

Institutional Backing Builds a Foundation

Institutional ownership has climbed to 71.78% of outstanding shares. Hong Kong-based CloudAlpha Capital Management disclosed a new position of 241,334 shares worth about $16.84 million. Vanguard, Baillie Gifford, and State Street have all added significantly to their stakes in recent reporting periods, signaling that Rocket Lab is increasingly seen as a long-term portfolio holding rather than a momentum trade.

Rocket Lab USA at a turning point? This analysis reveals what investors need to know now.

Vanguard alone now holds over 47 million shares, while Baillie Gifford has been an aggressive buyer. This institutional support provides a buffer against short-term volatility, even as the stock trades at elevated multiples.

The combination of a robotics acquisition that adds vertical integration, a record order book that provides revenue visibility, and a SpaceX IPO that resets industry valuations has created a powerful trifecta for Rocket Lab. The next real test will come this summer, when the SpaceX debut either validates or deflates the space rally.

Ad

Rocket Lab USA Stock: New Analysis - 21 May

Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab USA analysis...

en | US7731221062 | ROCKET | boerse | 69385765 |